A fascinating discussion popped-up today around strategies and tactics that pharma should use to engage with social media. Johnathan over at dose of digital started this discussion with this list ...
Patientslikeme announced last week: “ a pilot program in our multiple sclerosis community which helps patients submit treatment-related adverse events directly to the The U.S. Food and Drug Administration (FDA) ...
Do you know the feeling, when you come see something and you say to yourself: “Wow, this make just so much sense! I wonder why no one else has thought ...
Voilà a very clever initiative from GSK France illustrating how pharma can use its priviledged position at the cross-roads of many important influencers to drive positive change of the healthcare ...
